BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 594855)

  • 1. Immunodepression, ascites tumour and lactate dehydrogenase virus.
    Vincent MD; Potter JG; Cooper S
    S Afr Med J; 1977 Nov; 52(23):924-6. PubMed ID: 594855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase-elevating agent is responsible for interferon induction and enhancement of natural killer cell activity by inoculation of Ehrlich ascites carcinoma cells into mice.
    Koi M; Saito M; Ebina T; Ishida N
    Microbiol Immunol; 1981; 25(6):565-74. PubMed ID: 6168892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance.
    Hayashi T; Ozaki M; Mori I; Saito M; Itoh T; Yamamoto H
    Int J Exp Pathol; 1992 Apr; 73(2):173-81. PubMed ID: 1571277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed increase in plasma lactic dehydrogenase activity in mouse hepatitis virus-infected mice subsequently infected with lactic dehydrogenase virus.
    Dillberger JE; Monroy P; Altman NH
    Lab Anim Sci; 1987 Dec; 37(6):792-4. PubMed ID: 2830435
    [No Abstract]   [Full Text] [Related]  

  • 5. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of immunosuppressive agents with various activities in Ehrlich ascites fluid.
    Nitta K; Umezawa H
    Gan; 1975 Aug; 66(4):459-60. PubMed ID: 1183781
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition.
    Mongini PK; Rosenberg LT
    J Exp Med; 1976 Jan; 143(1):100-13. PubMed ID: 1244415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations in the isozyme spectrum and the activity of lactate dehydrogenase in development of Ehrlich ascites tumor].
    Agatova AI
    Vopr Med Khim; 1975; 21(3):276-81. PubMed ID: 1210105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Ehrlich ascites tumour growth on lactate dehydrogenase activities in tissues and physiological fluids of tumour bearing mice.
    Bengtsson G; Andersson G
    Int J Biochem; 1981; 13(1):53-61. PubMed ID: 6162685
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence and other characteristics of the lactate dehydrogenase-elevating virus (LDH-virus).
    Riley V
    Prog Med Virol; 1974; 18(0):198-213. PubMed ID: 4608417
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lactic dehydrogenase in the etiological diagnosis of serous effusions].
    Valdés EF; Schere M; Perazzo L; Abelini O
    Rev Clin Esp; 1967 Jan; 104(2):133-6. PubMed ID: 5596059
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific restoration of delayed hypersensitivity by lymphoid tissue extracts.
    Green JA; Williams J; Levy HB
    J Immunol; 1977 Jun; 118(6):1936-43. PubMed ID: 68074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes.
    Stevenson MM; Rees JC; Meltzer MS
    J Immunol; 1980 Jun; 124(6):2892-9. PubMed ID: 7373055
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of plasma clearance rates and immune response by negative charges: lactic dehydrogenase isoenzymes in normal and LDV-infected mice.
    Wachsmuth ED; Klingmüller D
    J Reticuloendothel Soc; 1978 Sep; 24(3):227-41. PubMed ID: 731629
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of three bleeding techniques on lactic dehydrogenase levels in mice: implications for lactic dehydrogenase virus bioassay.
    Dillberger JE; Monroy P; Altman NH
    Lab Anim Sci; 1987 Jun; 37(3):356-9. PubMed ID: 3613520
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of enzyme levels in the blood. Influence of environmental and genetic factors on enzyme clearance.
    Hayashi T; Salata K; Kingman A; Notkins AL
    Am J Pathol; 1988 Sep; 132(3):503-11. PubMed ID: 2843049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of LDH-5 from the circulation of inbred mice correlates with binding to macrophages.
    Hayashi T; Notkins AL
    Int J Exp Pathol; 1994 Jun; 75(3):165-8. PubMed ID: 8086313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate dehydrogenase-elevating virus.
    Rowson KE; Mahy BW
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2297-312. PubMed ID: 3903045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.